Direct effects of arsenic trioxide on action potentials in isolated cardiac tissues: importance of the choice of species, type of cardiac tissue and perfusion time.

INTRODUCTION The aim of the present study was to evaluate direct/acute effects of arsenic trioxide on action potentials (APs) in isolated cardiac tissues, and to investigate if the choice of species and tissue and the duration of the perfusion play a role in arsenic-induced acute/direct prolongation of AP/QT. METHODS AND RESULTS Direct electrophysiological effects of arsenic trioxide were measured in cardiac tissues isolated from four different species using micro-electrode recording. Arsenic (after 30 to 95 min perfusion at 10 μM) significantly prolonged APD(90), increased triangulation of the AP and elicited early afterdepolarizations (EADs) only in isolated guinea-pig and dog Purkinje fibers but not in rabbit and porcine (minipig) Purkinje fibers. Arsenic induced a prolongation of the APD(90) and increases in triangulation and the occurrence of EADs was not observed in papillary muscles of guinea-pigs and rabbits. Arsenic at 4 increasing concentrations from 0.1 μM to 10 μM at the standard perfusion-time of 15 min per concentration, and after a continuous 90-min perfusion at 1 μM and 1 Hz did not induce these direct effects on APD(90), triangulation and EADs in isolated guinea-pig Purkinje fibers, but it at 1 µM elicited EADs in 2 out of 7 preparations after 90 min at 0.2 Hz. DISCUSSION The present study demonstrates that the choice of species and cardiac tissue as well as perfusion-time play important roles in arsenic-induced direct/acute effects on APD(90) and induction of EADs in vitro.

[1]  J. Nezu,et al.  Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. , 2006, Journal of biomedical science.

[2]  A. Brown,et al.  Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG , 2003, Circulation research.

[3]  P. Agre,et al.  Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Bao-feng Yang,et al.  Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in Guinea pig. , 2006, Basic & clinical pharmacology & toxicology.

[5]  C. Obejero-Paz,et al.  Mechanisms of arsenic-induced prolongation of cardiac repolarization. , 2004, Molecular pharmacology.

[6]  Wei Tang,et al.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[7]  S. Soignet,et al.  Effect of arsenic trioxide on QT interval in patients with advanced malignancies. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Lau,et al.  Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety. , 2006, Blood.

[9]  C. Chiang,et al.  Effects of Arsenic Trioxide on Electrocardiography , 2004 .

[10]  K. Raghu,et al.  Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. , 2009, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[11]  H. R. Lu,et al.  Are there sex-specific differences in ventricular repolarization or in drug-induced early afterdepolarizations in isolated rabbit purkinje fibers? , 2000, Journal of cardiovascular pharmacology.

[12]  Björn Wagner,et al.  Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans , 2006, Drug safety.

[13]  G. Tomaselli,et al.  Drugs effects on ventricular repolarization: a critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices. , 2005, Journal of pharmacological and toxicological methods.

[14]  P. Adamson,et al.  Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. , 2008, Blood.

[15]  J. Dutcher,et al.  Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. , 2001, Blood.

[16]  D. Roden,et al.  Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents , 2003, Circulation.

[17]  C. Antzelevitch,et al.  Fever Accentuates Transmural Dispersion of Repolarization and Facilitates Development of Early Afterdepolarizations and Torsade de Pointes Under Long-QT Conditions , 2008, Circulation. Arrhythmia and electrophysiology.

[18]  Raymond L Woosley,et al.  Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  H. R. Lu,et al.  Both beta-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of I(Ks) channel blockers in vitro. , 2005, Journal of pharmacological and toxicological methods.

[20]  H. Utsumi,et al.  Effects of inorganic and organic arsenic compounds on growth and apoptosis of human T-lymphoblastoid leukemia cells. , 2011, Anticancer research.

[21]  Hua-rong Lu,et al.  Drug-induced long QT in isolated rabbit Purkinje fibers: importance of action potential duration, triangulation and early afterdepolarizations. , 2002, European journal of pharmacology.

[22]  U. Sanli,et al.  Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity , 2006, International Journal of Gynecologic Cancer.

[23]  Dan M. Roden,et al.  Clinical practice. Long-QT syndrome. , 2008, The New England journal of medicine.

[24]  R. Ohno,et al.  Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring , 2002, Leukemia.

[25]  H. R. Lu,et al.  Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines , 2008, British journal of pharmacology.

[26]  Baofeng Yang,et al.  The effect of arsenic trioxide on QT interval prolongation during APL therapy. , 2003, Chinese medical journal.

[27]  T. Soong,et al.  Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol Homeostasis* , 2011, The Journal of Biological Chemistry.

[28]  R. Ohno,et al.  Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia , 2000, Annals of Internal Medicine.

[29]  C. Chiang,et al.  Prolongation of cardiac repolarization by arsenic trioxide. , 2002, Blood.

[30]  S. Rafii,et al.  Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. , 2000, Blood.

[31]  Hua-rong Lu,et al.  Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation. , 2008, Journal of pharmacological and toxicological methods.

[32]  H. Katus,et al.  Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[33]  C. H. Cheng,et al.  Arsenic Trioxide, Arsenic Pentoxide, and Arsenic Iodide Inhibit Human Keratinocyte Proliferation through the Induction of Apoptosis , 2008, Journal of Pharmacology and Experimental Therapeutics.

[34]  T. Itoh,et al.  QT PRODACT: a multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles. , 2005, Journal of pharmacological sciences.

[35]  M K Pugsley,et al.  Principles of Safety Pharmacology , 2008, Handbook of Experimental Pharmacology.

[36]  Ard Teisman,et al.  Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit. , 2005, Journal of pharmacological and toxicological methods.

[37]  T. Ley,et al.  Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. , 2001, Blood.

[38]  Hua-rong Lu,et al.  Species Plays an Important Role in Drug‐Induced Prolongation of Action Potential Duration and Early Afterdepolarizations in Isolated Purkinje Fibers , 2001, Journal of cardiovascular electrophysiology.